ALPHA is a knowledge based, specialty pharmaceutical company.
It aims at developing differentiated products across a wide spectrum of therapeutic areas, by applying underlying rigorous scientific principles.
ALPHA serves the pharmaceutical needs of diverse markets worldwide through strong in-house R&D expertise in product development of complex drug molecules with specific emphasis in Oncology and Ophthalmology.
Developing complex Injectable such as lyophilized products, high potent drugs and long-acting products. Developed more than 35 Oncology Generics and specialty drugs. 40 dossiers have been filed across 25 countries of Emerging Market. 50+ generic dossiers been supported for filing with advanced markets covering wide therapeutic areas.

Company is looking for $4mn in debt to fuel its growth.

Register now to learn more about this business. Registration is free and takes only a few seconds.

Register Now

Already a DealStream member? .